Leuprolide

Back to search

Molecule Structure

Scientific Name

Leuprolide

Description of the Drug

Leuprolide is a peptide-based GnRH receptor superagonist used for the palliative treatment of prostate cancer, uterine leiomyomata, endometriosis, and central precocious puberty.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00007

Brand Name(s)

Not Available

Company Owner(s)

Ortho Mcneil Janssen Pharmaceutical Inc, Gp-Pharm Sa, Sandoz Inc, Teva Pharmaceuticals Usa, Tolmar International Ltd, Sun Pharmaceutical Industries Ltd, Foresee Pharmaceuticals Co Ltd, Abbvie Endocrine Inc, Tolmar Therapeutics Inc, Genzyme Corporation

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Gonadotropin-releasing hormone receptor SINGLE PROTEIN AGONIST CHEMBL1855

Unichem Links

SureChEMBL SCHEMBL4585
Human Metabolome Database HMDB0041916
WDI LEUPROREL
DrugBank DB00007
PubChem: Thomson Pharma 14890460 14841815 14939438 14939439
PubChem 657181
Nikkaji J34.477J
EPA CompTox Dashboard DTXSID50872411
DrugCentral 1559
ChemicalBook CB8398455
Guide to Pharmacology 1175
GSRS 105f0ac9-a55c-4d1e-bdae-9f01145a039a
rxnorm LUPRON LEUPROLIDE ELIGARD LEUPROLIDE ACETATE
ChEBI 6427